Navigation Links
Perfusion bioreactor could enhance stem cell research and application in the future

Florida State University researchers have now developed a new medical device that is believed to allow bone marrow derived stem cells to be grown in sufficient quantities to permit far more research and allow faster growth of// tissues. This overcomes the currently involved technical difficulties in the growth and transplantation of stem cells. The device called a perfusion bioreactor is designed to mimic conditions encountered by adult stem cells within the human body. The protein rich fluid produced by the reactor bathes the stem cell samples to provide nourishment by a parallel simulation of circulatory system. The perfusion bioreactor allows the delivery of essential nutrients in a physiological way. Furthermore, the researchers hope to alter the fate of each stem cell by altering the nutrient flow. If this is appropriately designed, the stem cell can give rise to a blood cell, nerve cell or a skin cell depending on the need. The stem cells derived from mesenchymal cells and processed in the bioreactor are viable for a period of 40 days and can be directed to differentiate into bone, cartilage, muscle, heart muscle, fat or nerve tissue. The stem cells produced in this way are ideally suitable for clinical transplantation. The current development overcomes the need of using fetal or embryonic tissue and eliminates the ethical concerns associated with the same as the mesenchymal stem cells can be extracted from adult donors. The stem cells for the present study were extracted through a medical procedure in which a small amount of bone marrow is extracted from the donors’ pelvic bone. Within that extracted bone marrow, only about one in every 100,000 cells is a stem cell. The rarity of finding bone marrow derived adult stem cell and technical difficulties involved in growth and multiplication of the stem cells posed a significant challenge to the researchers. However, the research team successfully overcame these shortcomings to achieve the desired resul ts. The present study may eventually pave way for significant breakthroughs in the field of stem cell research and application and help advance the development of numerous medical therapies in the years to come.
'"/>




Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: